Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: May 8, 2025
CANTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the first quarter ended March 31, 2025.
Read more at globenewswire.com
